General Information
Version
9.2
Revision date
2026-09-10
Product name
Naproxen Impurity C
CAS No.
84236-26-0
Emergency telephone
+81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H335, H361fd, H411
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. H411 Toxic to aquatic life with long lasting effects. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P202 Do not handle until all safety precautions have been read and understood. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. Reduced Labelling (<= 125 ml)
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H302: Harmful if swallowed. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Reproductive toxicity, Category 2 H361fd: Suspected of damaging fertility. Suspected of damaging the unborn child. Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, Category 3, Respiratory system Long-term (chronic) aquatic hazard, H411: Toxic to aquatic life with long lasting Category 2 effects.